Biologics is emerging as fastest growing field of drug development offering specificity and high therapeutic potential. However, their therapeutic efficacy is dependent on their route of administration and targeted delivery. Unlike small molecules, biologics face stability, permeability, solubility and immunogenicity challenges due to their inherent features. Hence tailored approaches are required in formulation development to assure their time-and site-specific action. In this review, we summarized the general and route-specific barriers that this group of drugs encounter once in contact with administration site. We listed the most common approaches to overcome the barriers and presented examples of different delivery systems that were proposed to deal with route-specific challenges. We also addressed the role devices play in assisted drug delivery and their choices related to expected use. We highlighted device-biologic combinations and discussed our perspectives on improving development using machine learning.
Overcoming barriers to delivery of biologics by novel approaches and, advanced delivery systems / S. Dela Ahator, S. Franze, S. Obuobi, G. Anderluzzi, G. Eide Flaten, N. Škalko-Basnet. - In: ADVANCED DRUG DELIVERY REVIEWS. - ISSN 0169-409X. - (2026). [Epub ahead of print] [10.1016/j.addr.2026.115875]
Overcoming barriers to delivery of biologics by novel approaches and, advanced delivery systems
S. FranzeSecondo
;G. Anderluzzi;
2026
Abstract
Biologics is emerging as fastest growing field of drug development offering specificity and high therapeutic potential. However, their therapeutic efficacy is dependent on their route of administration and targeted delivery. Unlike small molecules, biologics face stability, permeability, solubility and immunogenicity challenges due to their inherent features. Hence tailored approaches are required in formulation development to assure their time-and site-specific action. In this review, we summarized the general and route-specific barriers that this group of drugs encounter once in contact with administration site. We listed the most common approaches to overcome the barriers and presented examples of different delivery systems that were proposed to deal with route-specific challenges. We also addressed the role devices play in assisted drug delivery and their choices related to expected use. We highlighted device-biologic combinations and discussed our perspectives on improving development using machine learning.| File | Dimensione | Formato | |
|---|---|---|---|
|
review ADDR.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Licenza:
Creative commons
Dimensione
5.35 MB
Formato
Adobe PDF
|
5.35 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




